Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
ObjectiveTo formulate a decision analysis model based on recently published data that addresses the dilemma, whether improvement in quality of life rationalises continued proton pump inhibitors (PPI) use despite the risk of gastric cancer (GC) in patients with functional dyspepsia (FD).DesignA Marko...
Main Authors: | Efrat Broide, Adi Eindor-Abarbanel, Haim Shirin, Vered Richter, Shay Matalon, Moshe Leshno |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/2/e031091.full |
Similar Items
-
Lymphoid follicles in children with Helicobacter pylori-negative gastritis
by: Broide E, et al.
Published: (2017-08-01) -
Bedouin Children With Celiac Disease: Less Symptoms but More Severe Histological Features at Presentation
by: Baruch Yerushalmi, et al.
Published: (2020-09-01) -
The Perception among Israeli Gastroenterologists Regarding Treatment of Patients with Biosimilar Medications
by: Vered Richter, et al.
Published: (2023-03-01) -
Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia
by: Lucas Wauters, et al.
Published: (2021-12-01) -
Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood
by: Adi Eindor-Abarbanel, et al.
Published: (2021-11-01)